Home > Insider Trading > Filing (0001062993-21-011395)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1828522	Effector Therapeutics Inc.	EFTR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1225480	D Jonathan Root	1460 El Camino Real Suite 100 Menlo Park CA 94025		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-11-18	16,226	$8.53	4,549,398	No	4	S	Indirect	Directly owned by USVP X
Common Stock	Disposition	2021-11-18	519	$8.53	145,544	No	4	S	Indirect	Directly owned by AFF X
Common Stock	Disposition	2021-11-19	7,017	$8.12	4,542,381	No	4	S	Indirect	Directly owned by USVP X
Common Stock	Disposition	2021-11-19	224	$8.12	145,320	No	4	S	Indirect	Directly owned by AFF X
Common Stock	Disposition	2021-11-22	25,371	$7.86	4,517,010	No	4	S	Indirect	Directly owned by USVP X
Common Stock	Disposition	2021-11-22	812	$7.86	144,508	No	4	S	Indirect	Directly owned by AFF X

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Directly owned by USVP X
No	4	S	Indirect	Directly owned by AFF X
No	4	S	Indirect	Directly owned by USVP X
No	4	S	Indirect	Directly owned by AFF X
No	4	S	Indirect	Directly owned by USVP X
No	4	S	Indirect	Directly owned by AFF X

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $9.12; inclusive for sales on 11/18/21; prices ranging from $8.04 to $8.24, inclusive for sales on 11/19/21; and prices ranging from $7.75 to $8.06, inclusive for sales on 11/22/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4
Presidio Management Group X, L.L.C. ("PMG X"), the general partner of each of U.S. Venture Partners X, L.P. ("USVP X") and USVP X Affiliates L.P. ("AFF X") (together, the "USVP X Funds"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. The Reporting Person is a managing member of PMG X with additional rights with respect to the Issuer securities, and may be deemed to have sole voting and dispositive power with respect to the shares. The Reporting Person disclaims beneficial ownership of shares held by the USVP X Funds, except to the extent of any proportionate pecuniary interest therein.